Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05224791 · ClinicalTrials.gov registry record

A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy

A clinical trial of Sleeve Gastrectomy and Laparoscopic Sleeve Gastrectomy, sponsored by Methodist Health System.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT05224791: Recruiting study of Sleeve Gastrectomy and Laparoscopic Sleeve Gastrectomy, sponsored by Methodist Health System.

NCT05224791 is a study of Sleeve Gastrectomy and Laparoscopic Sleeve Gastrectomy that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 400 participants, above the 115-participant average among 8 other Sleeve Gastrectomy trials with a reported enrollment target (248% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05224791, a study of Sleeve Gastrectomy and Laparoscopic Sleeve Gastrectomy, is actively recruiting participants, sponsored by Methodist Health System.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The prevalence of obesity has tripled in the last 50 years with presently about 1.7 billion of the world population aged 18 years and over either overweight or obese.1 In the US alone, 35% of the population is obese.2 Although alternative surgical approaches are available, bariatric surgery results in substantial and durable weight reduction for the majority of patients, making it the most effective treatment for severe obesity.3 In the battle to reduce the invasiveness of bariatric procedures, laparoscopy has become the gold standard approach for virtually all bariatric surgery procedures in the years since it was first used for gastric bypass by Wittgrove and colleagues in 1993.5 Available data shows perioperative patient-oriented advantages of laparoscopy when compared with open surgery, including a shorter hospital stay, decreased postoperative pain, and enhanced postoperative recovery.6 The Agency for Healthcare Research and Quality (AHRQ) reported significant improvements in the safety of metabolic/bariatric surgery due in large part to improved surgical techniques.7 The risk of death is about 0.1%8 and the overall likelihood of major complications is about 4%.9 Performing bariatric surgery laproscopically can be demanding in many situations because of large livers and substantial visceral fat that limit the working space and make exposure, dissection, and reconstruction difficult.10 Similarly, thick abdominal walls may cause excessive torque on instruments. Under such situations, surgeons' ergonomics become a serious concern.11 Use of robotics in bariatric surgery has been evolving since Cadiere and colleagues reported the first case in 1999.12 Robotic surgery has provided the surgeons with the advantage of three-dimensional vision as well as increased dexterity and precision by downscaling surgeon's movements enabling a fine tissue dissection and filtering out physiological tremor.13 It overcomes the restraint of torque on ports from thick abdominal wall, an

Interventions

  • PROCEDURE Sleeve Gastrectomy
  • PROCEDURE Roux-en-Y Gastric Bypass

Study Locations (1)

Texas

  • Minimally Invasive Surgical Associates, Methodist Dallas Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2020-06-26
Est. Completion 2025-04-08
Methodist Health System

125 total trials

What NCT05224791 shows while recruiting

NCT05224791 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 115-participant average among 8 other Sleeve Gastrectomy trials with a reported enrollment target (248% higher).

The record links to 2 conditions, with Sleeve Gastrectomy appearing as the primary indexed condition, and to 2 interventions - of which Sleeve Gastrectomy is the first listed.

NCT05224791 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05224791 about?

NCT05224791 is a clinical study titled "A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy". The prevalence of obesity has tripled in the last 50 years with presently about 1.7 billion of the world population aged 18 years and over either overweight or obese.1 In the US alone, 35% of the population is obese.2 Although alternative surgical approaches are available, bariatric surgery results ...

What is the current status of trial NCT05224791?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-06-26. Estimated completion is 2025-04-08.

What conditions does trial NCT05224791 study?

This clinical trial studies the following conditions: Sleeve Gastrectomy, Laparoscopic Sleeve Gastrectomy.

What interventions are being tested in trial NCT05224791?

The interventions under investigation include: Sleeve Gastrectomy (PROCEDURE), Roux-en-Y Gastric Bypass (PROCEDURE).

Who is sponsoring clinical trial NCT05224791?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05224791 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleeve Gastrectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05224791's enrollment target sits among peer trials

400 1st of 8 higher than 8 of 8 other Sleeve Gastrectomy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sleeve Gastrectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05224791, the US trial registry maintained by the National Library of Medicine. NCT05224791 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.